Literature DB >> 17412917

Regulatory function of CD4+CD25+ T cells from Class II MHC-deficient mice in contact hypersensitivity responses.

Danielle D Kish1, Anton V Gorbachev, Robert L Fairchild.   

Abstract

Contact hypersensitivity (CHS) is a CD8+ T cell-mediated, inflammatory response to hapten sensitization and challenge of the skin. During sensitization, the magnitude and duration of hapten-specific CD8+ T cell expansion in the skin-draining lymph nodes (LN) are restricted by CD4+CD25+ T regulatory cells (Treg). The regulation of hapten-specific CD8+ T cell priming in Class II MHC-deficient (MHC-/-) mice was investigated. Although hapten-specific CD8+ T cell priming and CHS responses were elevated in Class II MHC-/- versus wild-type mice, presensitization depletion of CD4+ or CD25+ cells in Class II MHC-/- mice further increased CD8+ T cell priming and the elicited CHS response. Flow cytometry analyses of LN cells from Class II MHC-/- mice revealed a population of CD4+ T cells with a majority expressing CD25. Forkhead box p3 mRNA was expressed in LN cells from Class II MHC-/- and was reduced to background levels by depletion of CD4+ or CD25+ cells. Isolated CD4+CD25+ T cells from wild-type and Class II MHC-/- mice limited in vitro proliferation of alloantigen- and hapten-specific T cells to antigen-presenting stimulator cells. These results identify functional CD4+CD25+ Treg in Class II MHC-/- mice, which restrict hapten-specific CD8+ T cell priming and the magnitude of CHS responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412917     DOI: 10.1189/jlb.0207089

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  6 in total

1.  CD4+CD25+ regulatory T cells utilize FasL as a mechanism to restrict DC priming functions in cutaneous immune responses.

Authors:  Anton V Gorbachev; Robert L Fairchild
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

Review 2.  The role of OX40-mediated co-stimulation in T-cell activation and survival.

Authors:  William L Redmond; Carl E Ruby; Andrew D Weinberg
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

3.  Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression.

Authors:  William L Redmond; Todd Triplett; Kevin Floyd; Andrew D Weinberg
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

4.  CD154 and IL-2 signaling of CD4+ T cells play a critical role in multiple phases of CD8+ CTL responses following adenovirus vaccination.

Authors:  Channakeshava Sokke Umeshappa; Roopa Hebbandi Nanjundappa; Yufeng Xie; Andrew Freywald; Yulin Deng; Hong Ma; Jim Xiang
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

5.  NKG2D⁺ IFN-γ⁺ CD8⁺ T cells are responsible for palladium allergy.

Authors:  Mitsuko Kawano; Masafumi Nakayama; Yusuke Aoshima; Kyohei Nakamura; Mizuho Ono; Tadashi Nishiya; Syou Nakamura; Yuri Takeda; Akira Dobashi; Akiko Takahashi; Misato Endo; Akiyo Ito; Kyosuke Ueda; Naoki Sato; Shigehito Higuchi; Takeru Kondo; Suguru Hashimoto; Masamichi Watanabe; Makoto Watanabe; Tetsu Takahashi; Keiichi Sasaki; Masanori Nakamura; Takehiko Sasazuki; Takayuki Narushima; Ryuji Suzuki; Kouetsu Ogasawara
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

6.  Lack of MHC class II molecules favors CD8+ T-cell infiltration into tumors associated with an increased control of tumor growth.

Authors:  Nada Chaoul; Alexandre Tang; Belinda Desrues; Marine Oberkampf; Catherine Fayolle; Daniel Ladant; Alexander Sainz-Perez; Claude Leclerc
Journal:  Oncoimmunology       Date:  2017-12-07       Impact factor: 8.110

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.